This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Ray JA, Sabate E.Projected long-term economic outcomes associated with bevacizumab treatment in patients with adjuvant triple-negative breast cancer to inform early decision making. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 45-46 abstr. PCN51, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com
Rights and permissions
About this article
Cite this article
Bevacizumab adds value in triple-negative breast cancer. Pharmacoecon. Outcomes News 580, 6 (2009). https://doi.org/10.2165/00151234-200905800-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905800-00015